Turcsanyi, Lucia
Zhang, Xiao-Shuai https://orcid.org/0000-0001-5405-0802
Kudelka, Milos
Kubikova, Kristyna
Radvansky, Martin https://orcid.org/0000-0002-8421-7658
Yang, Sen
Kriegova, Eva
Juranova, Jarmila
Mayer, Jiri https://orcid.org/0000-0003-0567-9887
Klamova, Hana https://orcid.org/0009-0000-5020-7040
Belohlavkova, Petra
Karas, Michal
Stejskal, Lukas
Cmunt, Eduard
Othus, Megan https://orcid.org/0000-0001-8176-6371
Gale, Robert Peter https://orcid.org/0000-0002-9156-1676
Jiang, Qian https://orcid.org/0000-0001-7131-0522
Faber, Edgar https://orcid.org/0000-0002-3259-7791
Funding for this research was provided by:
Univerzita Palackého v Olomouci (IGA_LF_2025_014)
Univerzita Palackého v Olomouci (IGA_LF_2025_14)
Univerzita Palackého v Olomouci (IGA_LF_2025_05)
Univerzita Palackého v Olomouci (IGA_LF_2025_014)
Ministerstvo Zdravotnictví Ceské Republiky (MH CZ – DRO (FNOL, 00098892))
Ministerstvo Zdravotnictví Ceské Republiky (MH CZ – DRO (FNOL, 00098892))
Ministerstvo Zdravotnictví Ceské Republiky (MH CZ-DRO (FNOL 00098892))
Ministerstvo Zdravotnictví Ceské Republiky (MH CZ (FNOL, 00098892))
UK National Institute of Health Research
National Nature Science Foundation of China
Article History
Received: 9 January 2026
Revised: 10 February 2026
Accepted: 3 March 2026
First Online: 16 March 2026
Competing interests
: RPG: Consultant to Antengene Biotech LLC; Medical Director, FFF Enterprises Inc.; A speaker for Janssen Pharma and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support and Scientific Advisory Board, StemRad Ltd; QJ: speaker for Novartis and Ascentage Pharma Group, Inc.; EF: speaker for Novartis.
: Approved by the Ethic Committees of University Hospital Brno (01-290420/EK) and Peking University People’s Hospital, Peking University Institute of Haematology (2022PHB103-001). Subjects gave written informed consent consistent with the precepts of the revised Helsinki Declaration.